siRNA mediated knockdown of PHB1 and PHB2 in Kit225 cells significantly enhanced their sensitivity to ROS-induced cell death, suggesting a protective function in human hematologic tumor cells (Figure 3). This evidence concerns the gene PHB1 and hematopoietic and lymphoid cell neoplasm.